Lobe Sciences Ltd. (CSE:LOBE)

Canada flag Canada · Delayed Price · Currency is CAD
0.0500
-0.0050 (-10.00%)
Feb 9, 2026, 3:55 PM EST
Market Cap13.47M +292.7%
Revenue (ttm)n/a
Net Income-4.54M
EPS-0.03
Shares Out269.49M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume97,949
Average Volume68,518
Open0.0400
Previous Close0.0500
Day's Range0.0400 - 0.0500
52-Week Range0.0200 - 0.1100
Beta-0.25
RSI48.38
Earnings DateJan 28, 2026

About Lobe Sciences

Lobe Sciences Ltd., a biopharmaceutical company, engages in the research and development of lipid technology to develop innovative treatments for orphan and rare diseases. It offers Altemia® MF, a medical food designed to manage deficiencies in sickle cel disease. Lobe Sciences Ltd. was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. The company was founded in 2018 and is headquartered in Vancouver, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2018
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol LOBE
Full Company Profile

Financial Performance

Financial Statements